Focus: Rise Therapeutics is a 2022-founded biotech company developing orally bioavailable protein therapeutics for immunotherapy and biologics applications. Based in Rockville, MD, the company is pre-revenue and currently hiring across 25 roles.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Stable — net -3 jobs in 30d
6 added, 9 removed. Backfill posture.
Rise is a high-risk, high-reward pre-clinical platform play suitable for risk-tolerant professionals seeking equity upside and early-stage science impact, but unsuitable for those seeking near-term product launches or financial stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Rise Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Rise Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo